General Information of Drug (ID: DM0OYLQ)

Drug Name
I-vation Drug Info
Synonyms Triamcinolone implant
Indication
Disease Entry ICD 11 Status REF
Diabetic retinopathy 9B71.0 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM0OYLQ

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Corticosteroid-binding globulin (SERPINA6) TTJL8VG CBG_HUMAN Modulator [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Corticosteroid-binding globulin (SERPINA6) DTT SERPINA6 9.968 3.722 6.732 5.76
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Diabetic retinopathy
ICD Disease Classification 9B71.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Corticosteroid-binding globulin (SERPINA6) DTT SERPINA6 3.29E-04 -0.2 -0.2
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Drug delivery implants in the treatment of vitreous inflammation. Mediators Inflamm. 2013;2013:780634.
2 Cortisol binding in rat skeletal muscle. J Biol Chem. 1975 Feb 25;250(4):1207-11.